LA BioMed Scientists Make Breakthrough on Potential Vaccine For Deadly Fungal Infection

Team of scientists developed antibody-based treatment that prevented infection in mice

LOS ANGELES — Researchers from the Los Angeles Biomedical Research Institute (LA BioMed) and Vitalex Biosciences (a spinoff company of LA BioMed) helped lead an experiment that successfully immunized mice against mucormycosis, a fungal infection that is often fatal, potentially paving the way for the development of an immunotherapy for humans.